Final report of phase II study of sorafenib, cytarabine and idarubicin for initial therapy in younger patients with acute myeloid leukemia

F. Ravandi, C. Arana Yi, J. E. Cortes, M. Levis, S. Faderl, G. Garcia-Manero, E. Jabbour, M. Konopleva, S. O'Brien, Z. Estrov, G. Borthakur, D. Thomas, S. Pierce, M. Brandt, K. Pratz, R. Luthra, M. Andreeff, H. Kantarjian

Research output: Contribution to journalLetterpeer-review

Original languageEnglish (US)
Pages (from-to)1543-1545
Number of pages3
JournalLeukemia
Volume28
Issue number7
DOIs
StatePublished - Jul 2014

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this